NCT02804750: A reported trial by Corcept Therapeutics
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02804750 |
|---|---|
| Title | Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | June 30, 2016 |
| Completion date | Sept. 30, 2018 |
| Required reporting date | Sept. 30, 2019, midnight |
| Actual reporting date | Sept. 5, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |